跳至主要内容
临床试验/NCT04351490
NCT04351490撤回不适用

Impact of Zinc and Vitamin D3 Supplementation on the Survival of Institutionalized Aged Patients Infected With COVID-19

University Hospital, Lille0 个研究点开始时间: 2020年4月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
撤回
发起方
主要终点
Survival rate in asymptomatic subjects at inclusion

研究概览

简要总结

Mortality from Covid-19 increases with age, reaching 14.8% from the age of 80. The severity of the infection is linked to the acute respiratory distress syndrome (ARDS) which requires intensive care. ARDS is the consequence of the reactional inflammatory storm that damages the lungs.

Aged subjects are particularly prone to zinc and vitamin D deficiency. These two micronutrients are able to modulate the immune response by reducing the inflammatory storm.

The hypothesis is that supplementation with zinc and vitamin D would reduce the inflammatory reaction which worsens ARDS and leads to the death of subjects infected with Covid-19.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
60 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Institutionalized

排除标准

  • •Life expectancy < 1 month independently of Covid-19 infection (overall subjects)
  • •Known hypercalcemia
  • •History of renal lithiasis

研究组 & 干预措施

Group supplementation

Experimental

干预措施: 25-OH cholecalciferol (Dietary Supplement)

Group usual treatment

No Intervention

Group supplementation

Experimental

干预措施: Zinc gluconate (Dietary Supplement)

结局指标

主要结局

Survival rate in asymptomatic subjects at inclusion

时间窗: Two months after inclusion

次要结局

  • Survival rate in overall subjects(Two months after inclusion)
  • Cumulative incidence of Covid-19 infection in asymptomatic subjects at inclusion(Within two months after inclusion)
  • Survival rate in symptomatic subjects at inclusion(Two months after inclusion)

研究者

发起方
University Hospital, Lille
申办方类型
Other
责任方
Sponsor

相似试验